BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30334998)

  • 1. Sertoli-Leydig cell tumors of ovary: A case series.
    Xu Q; Zou Y; Zhang XF
    Medicine (Baltimore); 2018 Oct; 97(42):e12865. PubMed ID: 30334998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging, clinical, and pathologic findings of Sertoli-leydig cell tumors.
    Chen J; Liu Y; Zhang Y; Wang Y; Chen X; Wang Z
    Sci Prog; 2021; 104(2):368504211009668. PubMed ID: 33848213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
    Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant.
    Sarkar P; Sengupta M; Chatterjee U; Ghosh D
    Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
    Zhang HY; Zhu JE; Huang W; Zhu J
    Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary ovarian endometrioid adenocarcinoma: magnetic resonance imaging findings including a preliminary observation on diffusion-weighted imaging.
    Li HM; Qiang JW; Xia GL; Zhao SH; Ma FH; Cai SQ; Feng F; Fu AY
    J Comput Assist Tomogr; 2015; 39(3):401-5. PubMed ID: 25978592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
    Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
    Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
    Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature.
    Gressel GM; Buza N; Pal L
    Eur J Gynaecol Oncol; 2017; 38(2):214-220. PubMed ID: 29953783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian Sertoli-Leydig cell tumors: MRI findings and pathological correlation.
    Cai SQ; Zhao SH; Qiang JW; Zhang GF; Wang XZ; Wang L
    J Ovarian Res; 2013 Oct; 6(1):73. PubMed ID: 24160866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
    Virk R; Lu D
    Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases.
    Guo Y; Wang J; Li Y; Wang Y
    Arch Gynecol Obstet; 2020 Jul; 302(1):203-208. PubMed ID: 32430758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of imaging features of ovarian sclerosing stromal tumors on MRI and PET-CT: a case report and literature review.
    Matsutani H; Nakai G; Yamada T; Yamamoto K; Ohmichi M; Narumi Y
    J Ovarian Res; 2018 Dec; 11(1):101. PubMed ID: 30572921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
    Bhat RA; Lim YK; Chia YN; Yam KL
    J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
    Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
    Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors.
    Zhao S; Sun F; Bao L; Chu C; Li H; Yin Q; Guan W; Wang D
    J Ovarian Res; 2020 Jun; 13(1):71. PubMed ID: 32552845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature.
    Koo J; Garrington TP; Kerr K; Treece AL; Cost CR
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28621. PubMed ID: 32729194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of diffusion-weighted imaging combined with conventional magnetic resonance imaging in the diagnosis of thecomas/fibrothecomas and their differential diagnosis with malignant pelvic solid tumors.
    Yin B; Li W; Cui Y; Chu C; Ding M; Chen J; Zhang P; Wu X
    World J Surg Oncol; 2016 Jan; 14(1):5. PubMed ID: 26744173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of gynecological disease (2): clinical and ultrasound characteristics of Sertoli cell tumors, Sertoli-Leydig cell tumors and Leydig cell tumors.
    Demidov VN; Lipatenkova J; Vikhareva O; Van Holsbeke C; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):85-91. PubMed ID: 18098335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.